Intravenous magnesium reduces infarct size after ischemia/reperfusion injury combined with a thrombogenic lesion in the left anterior descending artery

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 3, 1999, Pages 569-574

  Ravn, Hanne B ^a,b   Moeldrup, Ulla ^a   Brookes, Carl I O ^c   Ilkjaer, Lars B ^a   White, Paul ^c   Chew, Michelle ^a,b   Jensen, Liselotte ^b   Johnsen, Soeren ^a   Birk Soerensen, Lene ^a   Hjortdal, Vibeke E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Animals; Magnesium; Platelets; Reperfusion injury; Thrombosis

Indexed keywords

MAGNESIUM SULFATE; PLACEBO; SODIUM CHLORIDE; THROMBOCYTE IN 111;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE ISCHEMIA; INTRAVENOUS DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE; THROMBOCYTE;

EID: 0033050498     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.3.569     Document Type: Article

References (23)

1. Christensen CW, Rieder M, Silverstein EL, Gencheff NE. Magnesium sulphate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation. 1995;92: 2617-2621.
2. Herzog WR, Schlossberg ML, MacMurdy KS, Edenbaum LR, Gerber MJ, Vogel RA, Serebruany VL. Timing of magnesium therapy affects experimental infarct size. Circulation. 1995;92:2622-2626.
3. Adams JH, Mitchell JRA. The effects of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo. Thromb Haemost. 1979;42:603-610.
4. Ravn HB, Kristensen SD, Hjortdal VE, Thygesen K, Husted SE. Early administration of intravenous magnesium inhibits arterial thrombus formation. Arterioscler Thromb Vasc Biol. 1997;17:3620-3625.
5. + channels. Circulation. 1996;93: 178-186.
6. Baan J, Van der Weide ET, Debruin HG Smeenk GJ, Koops J, van Dijk AD, Temmerman D, Senden J, Buis B. Continuous measurement of left ventricular volume in animals and humans by the conductance catheter. Circulation. 1984;70:812-823.
7. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194:927-929.
8. Antman EM. Magnesium in acute MI. Timing is critical. Circulation. 1995;92:2367-2372.
9. Gross GJ, Warltier DC, Daemmgen JW. Effects of AQ-AH 208 a new specific bradycardiac agent on myocardial ischemia-reperfusion injury in anesthethized dogs. J Cardiovasc Pharmacol. 1985;7:929-936.
10. Teo KK, Yusuf S, Collins R, Held PH, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ. 1991;303:1499-1503.
11. Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1992;339:1553-1558.
12. ISIS-4. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet. 1995;345:669-685.
13. Lang H. The creatine kinase BB isoenzyme. In Lang H, ed. Creatine Kinase Isoenzymes. Pathophysiology and Clinical Application. Berlin: Springer-Verlag; 1981:242-269.
14. Piper HM, Schwartz P, Spahr R, Hütter JF, Spieckermann PG. Early enzyme release from myocardial cells is not due to irreversible cell damage. J Moll Cell Cardiol. 1984;16:385-388.
15. Hwang DL, Yen CF, Nadler JL. Effect of extracellular magnesium on platelet activation and intracellular calcium mobilization. Am J Hypertens. 1992;5:700-706.
16. Gawaz M, Ott I, Reininger AJ, Neumann FJ. Effects of magnesium on platelet aggregation and adhesion. Magnesium modulates surface expression of glycoproteins on platelets in vitro and ex vivo. Thromb Haemost. 1994;72:912-918.
17. Ravn HB, Vissinger H, Kristensen SD, Husted SE. Magnesium inhibits platelet activity - an in vitro study. Thromb Haemost. 1996;76:88-93.
18. Ravn HB, Vissinger H, Kristensen SD, Wennmalm A, Thygesen K, Husted SE. Magnesium inhibits platelet activity - an infusion study in healthy volunteers. Thromb Haemost. 1996;75:939-944.
19. Herzog WR, Atar D, Gurbel PA, Vogel RA, Schlossberg ML, Serebruany VL. Effect of magnesium sulphate infusion on ex vivo platelet aggregation in swine. Magnes Res. 1993;6:349-353.
20. Dickens BF, Weglicki WB, Li YS, Mak IT. Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxity in endothelial cells. FEBS Lett. 1992;311:187-191.
21. Lawrence AG, Smith RS, Dejong SC, Martin SM, Beuttner GR, Kerber RE. Magnesium reduces free radicals in an in vivo occlusion-reperfusion model. Circulation. 1997;(Suppl I):I-K Abstract.
22. Leo R, Pratico D, Iuliano L, Pulcinelli FM, Ghiselli A, Pignatelli P, Colavita AR, FitzGerald GA, Violi F. Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated. Circulation. 1997;95:885-891.
23. Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Negri E, Santoro E, Tavazzi L, Tognoni G. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad Hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 data base. Circulation. 1993;88:416-429.